The BUZZZ this weekend is insane and word on the street is that theres are several MAJOR updates that will be unleashed this week to breakout EKNL in solid ‘core’ pick fashion.

EKNL IS OUR MONSTER 2012 PICK TO RIVAL DROPs $1.25 target (83,000% in gains)

As we have seen our 2011 monster Fuse Science (DROP) soar to hit our target of $1.25 (+83,000% gains) bang on soon after our special report was unleashed, EKNL is on the right track to do the same

Definitely people are stoked after we raised our price targets in our Special Report this weekend and for very good reasons.

Get the SPECIAL report here and see what price target we now have on EKNL. Continue reading →

Ticker: EKNL

Last traded: $0.125 +17.92%

Year-to-date High: $0.35

TARGET: $0.50

We are getting ready to unleashed our biggest special report this weekend and you definitely do not want to be on the sidelines for this. With huge buzz surrounding EKNL, several new investor groups started to jump in on the EKNL action last night with more to follow. Our special report this weekend will also be hitting our HUGE European base that will set up EKNL for the biggest breakout week yet!

SPECIAL REPORT RELEASED THIS WEEKEND DON’T MISS IT! Continue reading →

Ticker: EKNL

Last traded: $0.122 +15.09%

Year-to-date High: $0.35

TARGET: $0.50

EKNL released another MONSTER press release announcing an agreement with Meyers Institute – this is insane. With the Meyers institute now on board, this will open the doors to numerous other clinics to join forces with EKNL and FREMS technology. Can you say cha ching $$$!

• EKO International Corp – NeuroVasc Clinical Inc. to supply FREMS to first clinicPR Newswire(Thu 9:46AM EDT)

We are definitely stoked for our SPECIAL REPORT THIS WEEKEND and with this news just released definitely upped the stakes on price valuations.  Continue reading →

Ticker: EKNL

Last Closed: $0.106 +23.25%

Year-to-date High: $0.35

TARGET: $0.50

When you have 2 solid and steady green days up 160%+, and 2 HUGE press releases, this is primed for a MAJOR breakout rally that can send prices soaring big time. Not to mention that there’s only 8 Million shares in the float!

EKNL closed another outstanding session up 23.25% and into solid double digit levels of $0.106. EKNL is revving up it’s engine with solid press releases one after another, and hinting to many more to come

• EKO International Corp – Summary of NeuroVasc Clinical Inc.’s (NVCI) BusinessPR Newswire(Wed 12:20PM EDT)
• EKO International Corp – Distribution of Frequency Rhythmic Electrical Modulation SystemsPR Newswire(Tue Sep 25) Continue reading →

Ticker: EKNL

Last Trade: $0.106 +23.25%

Year-to-date High: $0.35

TARGET: $0.50

EKNL closed another outstanding session up 23.25% and into solid double digit levels of $0.106. EKNL is revving up it’s engine with solid press releases one after another, and hinting to many more to come

• EKO International Corp – Summary of NeuroVasc Clinical Inc.’s (NVCI) BusinessPR Newswire(Wed 12:20PM EDT)

MAJOR SPECIAL REPORT TO BE RELEASED THIS WEEKEND Continue reading →

Ticker: EKNL

Last Trade: $0.099 +15%

Year-to-date High: $0.35

TARGET: $0.50

EKNL just released another MONSTER press release showing the huge revenue potential their FREMS line of business can offer. This is getting xtreme!

• EKO International Corp – Summary of NeuroVasc Clinical Inc.’s (NVCI) BusinessPR Newswire(Wed 12:20PM EDT)

Key information from the news refers to some huge $$ potential here…

Each FREMS device can treat approx.  8-10 patients a day.
The sale of each FREMS device will generate approx. $ 8,000 of gross profit for EKO
Consumable supplies for each treatment will generate approx. $3.00 of gross profit for EKO

…now combined this with

It is estimated that there are 60 million diabetics in North American in 2012 and that number is climbing rapidly. Approximately 65% of diabetics will develop peripheral neuropathy, a painful and often irreversible condition affecting both lower limbs.

You have a recipe for HUGE potential Revenues and bottom line profits! Continue reading →

Ticker: EKNL

Last Trade: $0.086 +115%

Year-to-date High: $0.35

TARGET: $0.50

EKNL was the BEST performer and TOP gainer yesterday soaring 115% to close at $0.086 and on monster volumes of 2.5 Millions shares.
Being or new ‘CORE’ alert we will be featuring EKNL for at least 1 month and will definitely beat our most recent monster plays average gains.

Our last 5 picks, CMGO, USEI, AERS, SUTI, and SDSS gave member a potential 3,243%+ gains.   Continue reading →